Posted by Michael Wonder on 19 Sep 2022
Pharmacists can now prescribe Paxlovid, but barriers persist
19 September 2022 - Recently, the FDA expanded access to COVID-19 treatment by authorising state-licensed pharmacists to prescribe Paxlovid to eligible patients.
However, this expansion is limited by a requirement that pharmacists access patient records and the absence of a pathway to reimbursement for the required patient assessment.
If left unresolved, these barriers could undermine the Biden administration’s goals of providing equitable and timely access to this potentially life-saving therapy.
